New era of drug innovation in China
Acta Pharm Sin B
.
2019 Sep;9(5):1084-1085.
doi: 10.1016/j.apsb.2019.06.002.
Epub 2019 Jun 18.
Authors
Xuan Ye
1
,
Qingli Wang
1
,
Haixue Wang
1
Affiliation
1
Office of Pharmacology and Toxicology, Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China.
PMID:
31649856
PMCID:
PMC6804446
DOI:
10.1016/j.apsb.2019.06.002
No abstract available